Charity

Euroscicon managing director sets up a new charitable venture

Off

Dr Shara Cohen and Professor Tim CoxAt the end of July Euroscicon’s managing director  Dr Shara Cohen,  met with Professor Timothy Cox to discuss the way forward for Euroscicons new charitable arm RareCareUK.

Professor Cox has a long standing interest in forwarding research in the rare diseases.

His laboratory is currently developing gene therapy for serious neurodegenerative disorders, including Tay-Sachs and Sandhoff diseases and plays a major role in researching the causes of and developing treatments for  Krabbes disease and Gaucher disease.

In addition Professor Cox  and his group in Cambridge have  well established  links with charities and Government-sponsored bodies, which can help bring laboratory work  to the patients who need to benefit from the research.

Dr Cohen said “we hope that RareCareUK will have a long and rewarding relationship with Professor Cox and thank him for his time, ongoing support and most of all his enthusiasm for what we are hoping to achieve”.

Euroscicon Supports Rare Care UK

Caring for the neglected rare diseases. RareCareUK will provide Care for now, hope for future and the ability to play a role in achieving this.

RSS Free Biotechnology & Pharmaceuticals Magazines

  • How Automation can Liberate Healthcare from Dependencies and Limitations
    The COVID-19 pandemic has laid bare some of healthcare's most entrenched limitations, including a reliance on in-person visits, staffing shortages and a tendency to exclude IT from conversations about the organization's overall goals.   During Becker’s Hospital Review’s 12th Annual Meeting, in a session sponsored by IBM Watson Health, three company leaders — Steve Vance, […]